Ann Thorac Surg 2006;81:2272
© 2006 The Society of Thoracic Surgeons
Original article: Cardiovascular
Invited commentary
Brian W. Duncan, MD
Pediatric and Congenital Heart Surgery, The Children's Hospital, The Cleveland Clinic, 9500 Euclid Ave, Cleveland, OH 44195
(Email: duncanb@ccf.org).
| The first 20% of the full text of this article appears below. |
Despite decades of utility in the management of children with medically refractory heart failure, few definitive guidelines exist regarding indications for the institution of extracorporeal membrane oxygenation (ECMO) in the management of these patients. Similarly, precise measurements are lacking that identify children with sufficient ventricular recovery to allow weaning from ECMO support. Assessment of serum brain natriuretic peptide (BNP) as a biomarker of the neurohumoral response to cardiac disease has been shown to have prognostic value for acute and chronic . . . [Full Text of this Article]
Copyright © 2006 by The Society of Thoracic Surgeons.